Potential drug target, inhibitor identified for SARS-CoV-2
Risk factors identified for death from COVID-19
Coronavirus protein mapped by scientists
Strength training can protect the brain from degeneration
Predicting and slowing the progression of Parkinson's disease
Potential drug target, inhibitor identified for SARS-CoV-2
Two new studies out of the US show promise for the treatment of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).
New cancer treatments can activate tuberculosis infection
New checkpoint inhibitor treatments for cancer can activate tuberculosis in some patients — an infection that used to kill one in three people in the UK.
London patient cured of HIV, study claims
A case report has detailed the second claimed incidence of a patient cured of HIV, with no active viral infection detected 30 months after stopping antiretroviral therapy.
Risk factors identified for death from COVID-19
Being of an older age, showing signs of sepsis and having blood clotting issues when admitted to hospital are key risk factors associated with higher risk of death from the...
Our own immune cells damage the blood–brain barrier
Microglia regulate the permeability of the brain's protective barrier in response to systemic inflammation — but the process can sometimes go wrong.
Potential drug target, inhibitor identified for SARS-CoV-2
Two new studies out of the US show promise for the treatment of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).
-
Alzheimer's drug candidates found to reverse broader ageing
The drug candidates may be useful for treating a broad array of conditions, and suggest a new...
-
-
Medtech community shares the secrets of commercialisation
Saving and improving lives by making it easier to develop medical devices with electronics and...
-
-
Drug development process — from the start
According to Fredrik Sundberg, PhD, global director of strategic customer relations at GE...
-
Risk factors identified for death from COVID-19
Being of an older age, showing signs of sepsis and having blood clotting issues when admitted to hospital are key risk factors associated with...
-
Strength training can protect the brain from degeneration
Six months of strength training (lifting weights) can help protect brain areas especially...
-
-
Predicting and slowing the progression of Parkinson's disease
Two recent studies have provided new hope for Parkinson's patients, offering potential...
-
-
Rogue cells at the root of autoimmune disease
Cellular genomics technology has allowed researchers to reveal genetic mutations causing rogue...
-
Childhood flu exposure impacts future susceptibility
The first type of influenza virus we are exposed to in early childhood dictates our ability to fight the flu for the rest of our lives, according...
-
Coronavirus successfully grown in Melbourne lab
Melbourne scientists have successfully grown the Wuhan coronavirus from a patient sample, while...
-
-
Whooping cough vaccine may prevent food allergies — but will it protect against superbugs?
The vaccine might reduce cases of childhood food allergies — but whooping cough bacteria...
-
-
Fishing for proteins… and answers
Using a microscopic 'fishing' technique, scientists have successfully cast lines into...
-
Coronavirus protein mapped by scientists
Researchers have created a 3D atomic-scale map of the part of the novel coronavirus that attaches to and infects human cells, known as the spike...
-
Genetically modified mozzies completely resistant to dengue
Scientists have engineered what is claimed to be the first breed of genetically modified...
-
-
New gene editing tool could improve on CRISPR
US scientists have captured the first images of a new gene editing tool that could improve on...
-
-
Light-activated cells produce insulin for diabetics
Researchers transplanted engineered pancreatic beta cells into diabetic mice, then caused the...
-
Award-winning digital innovations for the health sector
The winning entries in the 2015 national iAwards have brought a range of benefits to a variety of sectors — with the health sector being no...
-
From little grants big labs grow
The Monash Institute of Pharmaceutical Sciences has officially opened its new laboratory —...
-
-
A non-exclusive licence agreement for LBT and bioMérieux
LBT Innovations and bioMérieux have converted their exclusive licence...
-
-
UTS opens state-of-the-art health and science building
UTS's Faculty of Science and Graduate School of Health Building - the third major development...
-
